These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22470869)

  • 21. A multiregional Italian cohort of 24-hour urine metabolic evaluation in renal stone formers.
    Esperto F; Marangella M; Trinchieri A; Petrarulo M; Miano R
    Minerva Urol Nefrol; 2018 Feb; 70(1):87-94. PubMed ID: 28882031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
    Huynh LM; Dianatnejad S; Tofani S; Carrillo Ceja R; Liang K; Tapiero S; Jiang P; Youssef RF
    Scand J Urol; 2020 Dec; 54(6):456-462. PubMed ID: 33185135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic characteristics of the elderly with recurrent calcium oxalate stones.
    Yagisawa T; Hayashi T; Yoshida A; Okuda H; Kobayashi H; Ishikawa N; Goya N; Toma H
    BJU Int; 1999 Jun; 83(9):924-8. PubMed ID: 10368230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis.
    Damasio B; Massarino F; Durand F; Banchero R; Bottino P; De Franchis V; Carmignani G; Cannella G
    J Nephrol; 2005; 18(3):262-6. PubMed ID: 16013013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic evaluation in patients with nephrolithiasis: A report from Isfahan, Iran.
    Emami-Naini A; Eshraghi A; Shahidi S; Mortazavi M; Seyrafian S; Roomizadeh P; Abtahi SH; Ghafoori HB
    Adv Biomed Res; 2012; 1():65. PubMed ID: 23326796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of distal renal tubular acidosis in patients with calcium phosphate stones.
    Guimerà J; Martínez A; Tubau V; Sabate A; Bauza JL; Rios A; Lopez M; Piza P; Grases F; Pieras E
    World J Urol; 2020 Mar; 38(3):789-794. PubMed ID: 31079188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nephrolithiasis in renal tubular acidosis.
    Buckalew VM
    J Urol; 1989 Mar; 141(3 Pt 2):731-7. PubMed ID: 2645431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of urinary abnormalities in urolithiasis patients: A study from North India.
    Kumar R; Kapoor R; Mittal B; Kumar A; Mittal RD
    Indian J Clin Biochem; 2003 Jul; 18(2):209-15. PubMed ID: 23105414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of Urine Composition of Patients With Recurrent Nephrolithiasis in Lorestan, Iran.
    Hadian B; Zafar-Mohtashami A; Ghorbani F
    Iran J Kidney Dis; 2018 Jan; 12(1):22-26. PubMed ID: 29421773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term treatment of calcium nephrolithiasis with potassium citrate.
    Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
    J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic and Genetic Evaluation in Children with Nephrolithiasis.
    Mandal A; Khandelwal P; Geetha TS; Murugan S; Meena J; Jana M; Sinha A; Kumar R; Seth A; Hari P; Bagga A
    Indian J Pediatr; 2022 Dec; 89(12):1243-1250. PubMed ID: 35819704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. National multi-institutional cooperative on urolithiasis in children: Age is a significant predictor of urine abnormalities.
    Cambareri GM; Kovacevic L; Bayne AP; Giel D; Corbett S; Schurtz E; Sukhu T; Chiang G
    J Pediatr Urol; 2015 Aug; 11(4):218-23. PubMed ID: 26119451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone disease in medullary sponge kidney and effect of potassium citrate treatment.
    Fabris A; Bernich P; Abaterusso C; Marchionna N; Canciani C; Nouvenne A; Zamboni M; Lupo A; Gambaro G
    Clin J Am Soc Nephrol; 2009 Dec; 4(12):1974-9. PubMed ID: 19808216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features.
    McPhail EF; Gettman MT; Patterson DE; Rangel LJ; Krambeck AE
    Urology; 2012 Feb; 79(2):277-81. PubMed ID: 22014971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of dietary inflammatory index with urinary risk factors of kidney stones formation in men with nephrolithiasis.
    Maddahi N; Yarizadeh H; Aghamir SMK; Alizadeh S; Yekaninejad MS; Mirzaei K
    BMC Res Notes; 2020 Aug; 13(1):373. PubMed ID: 32771046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low urinary citrate excretion in nephrolithiasis.
    Nicar MJ; Skurla C; Sakhaee K; Pak CY
    Urology; 1983 Jan; 21(1):8-14. PubMed ID: 6823713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management.
    Bamberger JN; Blum KA; Kan KM; Parkhomenko E; Gallante B; Gupta M
    J Endourol; 2019 Sep; 33(9):755-760. PubMed ID: 31154910
    [No Abstract]   [Full Text] [Related]  

  • 39. Preventive Kidney Stones: Continue Medical Education.
    Assadi F; Moghtaderi M
    Int J Prev Med; 2017; 8():67. PubMed ID: 28966756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ability of a limited metabolic assessment to identify pediatric stone formers with metabolic abnormalities.
    Chan KH; Moser EA; Whittam BM; Misseri R; Cain MP; Krambeck A
    J Pediatr Urol; 2018 Aug; 14(4):331.e1-331.e6. PubMed ID: 30177386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.